Mark A. Velleca, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark A. Velleca, M.D., Ph.D.
Mark A. Velleca, M.D., Ph.D. is recorded as CEO and Chairman at Black Diamond Therapeutics, Inc. (BDTX). Black Diamond Therapeutics, Inc. reported in an 8-K filed December 19, 2022 that Mark A. Velleca, M.D., Ph.D. was appointed Chairman of the Board, effective December 15, 2022.
“On December 15, 2022, upon the recommendation of the NCG Committee, the Board appointed current Board member Mark A. Velleca, M.D., Ph.D. to serve as Chairman of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-16–present
-
Current
2022-12-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Black Diamond Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Mark A. Velleca CEO
- Mark Velleca CEO
- Mark Velleca, M.D., Ph.D. CEO, Board Member
- Erika Jones CFO, Chief Accounting Officer
- Thomas Leggett CFO
- Brent Hatzis-Schoch COO
- Kapil Dhingra Board Member
- Prakash Raman, Ph.D. Board Member
- Robert A. Ingram Board Member
- Shannon Campbell Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.